text:
New York Court Rejects Application of Equitable Relief Sublimit and I v. I Exclusion
A New York appellate court has held that a sublimit in a professional liability insurance policy for claims seeking equitable relief does not apply to counts within a lawsuit seeking legal relief. Trustees of Princeton Univ. v. Nat'l Union Fire Ins. Co., 2008 WL 2277830 (N.Y. App. Div. Jun. 5, 2008). The court also held that the policy's insured v. insured exclusion does not apply to allegations against insured entities by individual insureds acting in their individual capacities and that the policy obligated the insurer to advance defense costs as they are incurred with a right to seek recoupment of non-covered costs after the suit is resolved.
The policy was issued to a university, its subsidiaries and their trustees. One of the subsidiaries was a family-endowed foundation. The family-appointed trustees of the foundation accused the university-appointed trustees of mismanaging the foundation's endowment. The family-appointed trustees and the donors' surviving children filed a suit against the university, the foundation and the university-appointed trustees of the foundation. The suit alleged legal and equitable causes of action, including several derivative causes of action brought by the plaintiffs on behalf of the foundation.
When the insurer denied coverage for the suit, the university sued the insurer, seeking reimbursement for defense costs already paid, which exceeded the policy's limit and its sublimit for claims for equitable relief. On appeal, the appellate court first held that the sublimit for claims seeking equitable relief did not extend to claims seeking legal relief. The sublimit provided that "for Claims involving multiple allegations, the . . . sublimit will only apply to the portion of the Claim which is related to the equitable or injunctive relief allegations." Without addressing the policy's definition of "Claim," the court refused to apply the sublimit "to claims arising from the same underlying occurrence that seek relief based on tort and contract law principles," stating that such a position "relies on a strained construction of the terms of the policy."
The court then held that the insured v. insured exclusion applied only to "derivative claims explicitly brought on behalf of the [foundation]," thus allowing the remaining causes of action to proceed. The insured v. insured exclusion provided that "[t]he Insurer shall not be liable to make any payment for Loss in connection with a Claim made against an Insured . . . which is brought by or on behalf of the Organization [including the foundation] against any Individual Insured; provided however, this exclusion shall not apply to any derivative Claim made on behalf of the Organization by a member or any other such representative party if such action is brought and maintained independently of and without the solicitation of or assistance of, or active participation of or intervention of any Individual Insured or the Organization or any Affiliate thereof." Without addressing the policy's definition of "Claim," the court rejected "the contention that the policy's 'insured versus insured' exclusion applies to claims brought against the insured entities by individual insureds acting in their individual capacities."
Finally, the appellate court stated that because "the policy obligates [the insurer] to advance all defense costs as they are incurred, subject to a right of recoupment of payment for non-covered costs after the underlying litigation is completed, [the trial court] had no obligation at this juncture to rule on the allocation of defense expenses."


text:
Q: primefaces ajax update element i have a behaviour here i don't understand. I am using Spring 3.1, Primefaces 3.3.1 and JSF 2.
I am using a datatable and want to add a row via a dialog within a form.
This is my table, including the button to call the dialog:
<h:form id="form">

            <!-- open the dialog on click -->
    <p:commandButton value="New" onclick="dlgAddTask.show()"
        update="taskList" />

    <p:dataTable var="task" value="#{taskBean.tasks}" id="taskList"
        widgetVar="taskList" editable="true" rowkey="task.id"
        paginator="true" rows="50"
        paginatorTemplate="{CurrentPageReport}  {FirstPageLink} {PreviousPageLink} {PageLinks} {NextPageLink} {LastPageLink} {RowsPerPageDropdown}"
        rowsPerPageTemplate="25,50,100">

        <p:ajax event="rowEdit" update="@this" listener="#{taskBean.save}" />

        <p:column headerText="Name" style="width:125px">
            <p:cellEditor>
                <f:facet name="output">
                    <h:outputText value="#{task.name}" style="width:100%" />
                </f:facet>
                <f:facet name="input">
                    <p:inputText value="#{task.name}" style="width:100%" />
                </f:facet>
            </p:cellEditor>
        </p:column>

        <p:column style="width:20px">
            <p:rowEditor />
        </p:column>

    </p:dataTable>

</h:form>

This is my dialog with the relevant javascript (it's in the same form as the table is):

    <p:dialog id="dlgAddTask" header="Add New Task" widgetVar="dlgAddTask">
        <h:form>

            <h:panelGrid columns="2" cellpadding="5" width="500">
                <h:outputLabel for="name" value="Name" />
                <p:inputText value="#{addTaskBean.name}" id="name" required="true"
                    label="name" />

                <h:outputLabel for="description" value="Description:" />
                <p:inputTextarea value="#{addTaskBean.description}"
                    id="description" label="description" />

                <h:outputLabel for="dueTo" value="Due To:" />
                <p:calendar value="#{addTaskBean.dueTo}" id="dueTo" label="dueTo" />

                <h:outputLabel for="done" value="Done:" />
                <p:selectBooleanCheckbox value="#{addTaskBean.done}" id="done"
                    label="done" />

                <f:facet name="footer">
                    <p:commandButton id="addButton" value="Add"
                        actionListener="#{addTaskBean.addTask}"
                        oncomplete="handleLoginRequest(xhr, status, args)" />

                    <p:commandButton value="Cancel" onclick="dlgAddButton.hide()" />
                </f:facet>
            </h:panelGrid>

        </h:form>
    </p:dialog>

    <script type="text/javascript">
            function handleLoginRequest(xhr, status, args) {
                if (args.validationFailed || !args.taskAdded) {
                    jQuery('#dialog').effect("shake", {
                        times : 3
                    }, 100);
                } else {
                    dlgAddTask.hide();
                }
            }
        </script>

</h:form>

And this is my Bean (leaving out the getter and setter):
public class AddTaskBean {

@Inject
TaskDao taskDao;

private boolean done;

private String name;

private String description;

private Date dueTo;

@Transactional
public void addTask() {

    RequestContext context = RequestContext.getCurrentInstance();
    FacesMessage msg = null;
    Task task = new Task();
    boolean taskAdded = false;

    task.setDescription(getDescription());
    task.setDone(isDone());
    task.setDueTo(getDueTo());
    task.setName(getName());

    if (taskDao.persist(task) != null) {
        taskAdded = true;
        msg = new FacesMessage(FacesMessage.SEVERITY_INFO, "Task",
                getName() + " added.");
    } else {
        taskAdded = false;
        msg = new FacesMessage(FacesMessage.SEVERITY_WARN, "Task Error",
                "Something went wrong on adding task.");
    }

    FacesContext.getCurrentInstance().addMessage(null, msg);
    context.addCallbackParam("taskAdded", taskAdded);

}

Now, if i open the dialog, add a task, it works up to the update point. So i have a new task in the database, the dialog closes, but the table does not get updated.
Hitting F5 shows me the new task in the table.
But (please read carefully as it is a bit tricky to explain for me), if i dont close the dialog after adding a task (by not calling the javascript via oncomplete="handleLoginRequest(xhr, status, args)"), the task will be added too, but the dialog remains open of course.
If i press cancel then, the dialog closes and the table get's updated and i can see the new task.
I cannot explain this, maybe one of you can?
Thanks in Advance

redpajama_set_name: RedPajamaStackExchange


TW Chat Room > Categories > F.W.I.W. Department > Possible Warning Flag for Bullish Case?
One of the numerous outputs of a collaborative NYSE data crunching project led by Tom McClellan is an indicator derived by multiplying the daily price change of each issue traded on the NYSE by the issue's respective volume. If the stock advanced for the day, the price-change/volume product is in the up price change volume column, if the component's price declined for the day, its price-change/volume product is in the down price change volume column.
Have to get to work, so will only post the cumulative price-change volume line for this indicator, and will address the McClellan tool variants of this data later. Below is the cumulative price-change volume ($PCV) line over the past couple of years... note the divergence in strength of the $PCV line versus the NYA.
Next is a longer term look at the $PCV line. Note this indicator ignored price rally attempts during 2002 and early 2003, and started rising in a meaningful manner only after the March 2003 price bottom.
Seems like if the price bottom was indeed behind us, this indicator would be confirming the recent price rally.
This caught my attention. It would be interesting to look at other time frames for such divergences. Messed with a few TLs on your chart. The other times marked in rectangles, the $Wtd P-C UD V. Line continued lower while the NYA double or triple bottomed. So, it does beg the question as to whether the NYA has yet to establish its bottom via a retest.
Not sure if this helpful, but thought it might add to the overall prediction as to IT trend. The charts are suggesting that if BOP (money flow) erodes enough to break the 34ema trend, then price will top out very soon thereafter. A break of the 89 week BOP would set up a LT price decline.


text:
The Gates of Firestorm Peak (1996): Greatest D&D Adventures Since 1985—Number 10
The Gates of Firestorm Peak (1996) is a second-edition Advanced Dungeons & Dragons adventure by Bruce Cordell for levels 5-8.
When TSR introduced the second-edition Player's Option books, new designer Bruce Cordell drew the job of writing an adventure highlighting the supplements.
The Combat & Tactics supplement introduced the maps-and-minis, grid-based style of combat that would come to dominate third and fourth edition. For that, the adventure packages monster tokens, and vivid—almost psychedelic—battlemaps for key locations.
For characters upgraded with Skills & Powers, The Gates of Firestorm Keep brings tough combat challenges against organized duergar resistance.
After passing the duergar guarding the gate, the party can continue through more combat, or stealth, or an alliance with a duergar usurper. Reviewer Will Mistretta writes, "Firestorm Peak is strongly non-linear, with more than one way to tackle the dungeon's challenges."
Never content to build a dungeon around a mere ruin or hole in the ground, Cordell begins with a evocative premise: "Once a generation, they say, a strange comet appears in the sky overhead and the gates of Firestorm Peak swing open." One player has the option of casting their character as the offspring of an adventurer who disappeared in the mountain 28 years ago.
The adventure starts as a tactical challenge, but it veers into fresh territory. "Anyone who's been a gamer long enough reaches a stage where he or she begins to feel like it's all been done," John D. Rateliff says. "This adventure is evidence that fresh talent will always come along and do the familiar with so much verve and so many personal touches that it all seems new again."
As the party delves deeper and starts unraveling the peak's mystery, the story creeps into the weird territory of things we're not meant to know. "It positively oozes freaky flavor," writes Mistretta. "The alien life forms infesting the depths of the dungeon are truly unsettling in their aspect and the gradual transition from a classic Underdark romp to the heart of an otherworldly foulness is handled quite deftly."
Firestorm Peak introduced the Far Realm, a Lovecraftian dimension of insanity and horror. "It got a lot of attention because it was evocative and focused on one of D&D's influences that had long been neglected—the Cthulhu mythos," Shannon Appelcline writes in his product history. "The Gates of Firestorm Peak was also the adventure that changed the way people thought about D&D aberrations. Beforehand, they were wizardly experiments gone wrong, but afterward they were more frequently associated with Lovecraftian monstrosities."
The Gates of Firestorm Peak ranked 11 on Dungeon magazine's 2004 list of 30 greatest adventures.
Next: Number 9.
This entry was posted in Role-playing game history and tagged Bruce Cordell, Far Realm, Gates of Firestorm Keep, greatest adventures, Player's Option: Combat & Tactics, Shannon Appelcline on May 29, 2019 by David Hartlage.
← Why Did So Many Classic Adventures Come From 7 Years of D&D's 45-Year History? Tomb of Annihilation (2017): Greatest D&D Adventures Since 1985—Number 9 →
17 thoughts on "The Gates of Firestorm Peak (1996): Greatest D&D Adventures Since 1985—Number 10"
Pingback: Why Did So Many Classic Adventures Come From 7 Years of D&D's 45-Year History? | DMDavid
J David Chrisman May 29, 2019 at 7:45 am
A great review – thanks for sharing!
brucercordell May 29, 2019 at 4:10 pm
Thanks for the review! Much appreciated :). If you're interested, I wrote about designing the Gates of Firestorm Peak a few months ago, and the associated creation of The Far Realm (which certainly got its name in Gates, but which I further highlighted in later adventures to strengthen its importance): http://brucecordell.blogspot.com/2019/03/origin-of-far-realm-in-d.html
alphastream May 30, 2019 at 3:20 am
Reading that post was a lot of fun. I really enjoyed the Abolethic Sovereignty series of novels. Really creepy, with superbly interesting characters.
PS May 29, 2019 at 7:22 pm
Nice, I did no know this one. This would work great for my group. I will pick it up on DMG.
It is no shock at all to see Bruce Cordell on this list! It won't surprise me if we see his name again in the top 10. It's fun to read about people remarking on his coming in as new talent with new ideas. That's really cool to think back on that. I like how Bruce (even today with MCG) has a real gift for suffusing an adventure setting with vivid flavor.
Pingback: Lost Mine of Phandelver (2014): Greatest D&D Adventures Since 1985—Number 3 | DMDavid
Pingback: Tomb of Annihilation (2017): Greatest D&D Adventures Since 1985—Number 9 | DMDavid
Pingback: Sunless Citadel (2000): Greatest D&D Adventures Since 1985—Number 8 | DMDavid
Pingback: Vault of the Dracolich (2013): Greatest D&D Adventures Since 1985—Number 7 | DMDavid
Pingback: Madness at Gardmore Abbey (2011): Greatest D&D Adventures Since 1985—Number 6 | DMDavid
Pingback: Dead Gods (1997): Greatest D&D Adventures Since 1985—Number 5 | DMDavid
Pingback: Curse of Strahd (2016): Greatest D&D Adventures Since 1985—Number 4 | DMDavid
Pingback: Night's Dark Terror (1986): Greatest D&D Adventures Since 1985—Number 1 | DMDavid
Pingback: The 10 Greatest Dungeons & Dragons Adventures Since 1985 | DMDavid
Pingback: Making the List of 10 Greatest D&D Adventures After 1985 | DMDavid

redpajama_set_name: RedPajamaCommonCrawl


text:
Q: Change a letter in a file to uppercase in Shell script I'm trying to change a specific given letter to uppercase in a file, but I don't know how to do it. The file already exist and I want to do the following
cat merry.txt
I wish you a Merry Christmas

Change e to E so the output will be
cat merry.txt
I wish you a MErry Christmas

Thank you everyone

A: Try this :
sed 's/e/E/' merry.txt

If your text included more than one occurrence of "e" on a line, the preceding sed would
have changed just the first occurrence on each line to "E." By appending the global option
g to the end of the s command, you can ensure that multiple occurrences of the string on a line will be changed.
Try to use this :
sed 's/e/E/g' merry.txt

This command converts all e to E.
Or can use :
sed -i 's/e/E/g' merry.txt

A: Like this:
sed 's/e/\Ue/' Input_File

To edit permanently, add -i switch:
sed -i ...

A: You can use tr to "translate" a char to another char:
tr 'e' 'E' < file > newfile && mv newfile file

You can also use awk (here, a dynamic approach is used):
find='e'
replace='E'
awk -v f="$find" -v r="$replace" '{gsub(f, r)}1' file > newfile && mv newfile file

With GNU sed, you may use
sed -i 'y/e/E/' file

In all these case, you replace an e with E everywhere in the file and save the contents of the updated file under the same filename.
See a sample demo online:
#!/bin/bash
s='I wish them a Merry Christmas'
find='e'
replace='E'
tr "$find" "$replace" <<< "$s"
awk -v f="$find" -v r="$replace" '{gsub(f, r)}1' <<< "$s"
sed 'y/e/E/' <<< "$s"

Output: I wish thEm a MErry Christmas.


Few things bring people together like Super Bowl Sunday. I'm Paula from Celestial Hearing and I enjoy watching the game with friends and family. Often though, I'm thinking about how the experience might feel for people who have hearing loss. For one thing, it can be inspiring to know some of the information below about players in the game with hearing loss.
Also, it's important for everyone to pay attention to noise levels and protect their hearing whenever necessary, but it is especially vital for those who already have hearing issues. You may not be aware of the extent of the noise level, but it can still do further damage to your hearing.
Most people don't know that hearing loss is at the heart of one of the iconic images of American football – the huddle. This was originally a technique used by players at a deaf college back in 1820 to ensure that other teams couldn't see them signing strategies to each other.
The tradition of the hearing loss community's contribution to football continues in some of its major players. Derrick Coleman, the first legally deaf player in the NFL, famously featured in an inspirational ad for Duracell in 2014. In it, his stirring voice-over states that when, at first, they didn't pick him for the team, he didn't listen because he had been deaf since he was 3. This kind of determination led him to the Super Bowl XLVIII where he could hear all the fans cheering him on.
Kenny Walker beat spinal meningitis as a child, but he was left with profound deafness. Neither of these stopped him from playing NFL football for the Denver Broncos in the early 90s. Walker's quick wit and willingness to speak about the issues he has overcome has led to a few inspirational soundbites. He commented that he received the 'best ovation you never heard' during his last game at the University of Denver.
Wherever you watch the game, it's probably going to be loud. Cheering and music are all part of the show. You still want to be a part of all that, so consider how you are going to protect your ears during that time.
From adjusting your hearing aid capacity to using ear defenders, I can help you come up with a winning strategy which means your choices when it comes to the Super Bowl experience are not limited by hearing difficulties.
When it comes to hearing loss, Celestial Hearing is on your side. I offer advice, equipment and hearing assessment in La Cruces, New Mexico to enhance your enjoyment of the big game as well as other aspects of life. Contact me today to book an appointment to discuss your needs and create a tailored treatment plan.


text:
Globalist Perspective	Previous Next
The Multipolar World Vs. The Superpower
Is U.S. unilateralism a reality — or just a belief that U.S. strategists are trying to sell to the rest of the world?
By Sherle Schwenninger, December 5, 2003
Strategy by force?
A grand strategy, such as it is pursued by the Bush Administration, ultimately rests on the simple idea of a unipolar world — the notion that the United States is the only power that counts in the world today.
Coincidentally, that is also why neo-conservative advocates are so critical of France's avowed goal of creating a multi-polar world, attributing it to France's superpower "envy."
Yet for all practical purposes, a multipolar world already exists. On a global plane, the United States may appear to be the world's only superpower, spending more than the next 15 nations combined on military power.
But viewed at the level of its key strategic relationships with Europe, Russia, China and Japan, the United States in each case needs them to achieve its foreign policy goals as much — or more — than they need the United States.
In other words, at the bilateral level, the other established and emerging powers of the world enjoy either strategic parity with the United States — or a favorable balance of power and interest.
And the balance is likely to tilt further in favor of Europe, Russia, Japan and China in the future. This is in part because the U.S. market will become less important to them — and in part because the United States' growing dependence on foreign capital will increase its international debt burden.
This makes it more vulnerable to the policies and attitudes of its principal creditors.
Take the case of the U.S. relationship with the European Union. Unipolarists like to focus attention on Europe's military weaknesses — as well as the lack of a unified European foreign policy.
But contrary to conventional wisdom, Europe enjoys an attractive position vis-à-vis the United States. In the ultimate analysis, Washington needs the help and support of Europe more than Europe needs the United States.
Even more amazingly, if looked at objectively, Europe is no longer dependent on the United States for any real security or defense needs.
In fact, the European nations of NATO and the European Union now have primacy over their own security — and over the security of the immediate European Rim region, stretching from the Ukraine in the north to the Balkans in the south.
Certain Europeans might like the United States to do more to help create stability in Ukraine or maintain peace in Kosovo and Macedonia.
Yet Washington has essentially removed itself from these security-related concerns. Europe's main security worry vis-à-vis the United States today is of an entirely different nature.
It is not that Washington will abandon Europe, but that it will use its power in the Middle East in a way that will destabilize the region and create greater Western-Islamic tensions.
But even in this case, Europe may have more influence and leverage over the United States than has been commonly recognized.
Even though Washington is trying to build a flexible military structure that is less dependent on its allies, the United States still relies on European bases and infrastructure for non-NATO missions.
And it still needs a measure of European support and participation to gain domestic support for those missions.
Beyond this, Washington depends upon European Union members for peacekeeping and nation-building tasks. This is true not just in the Balkans — but in Afghanistan and most likely soon in Iraq.
The United States also benefits from European assistance for other U.S. security-related concerns, such as support for the Palestinian Authority.
This is not to mention the importance of Europe's active cooperation in stopping international terrorism and nuclear weapons proliferation.
In many ways, Europe is better positioned to pursue a project to build democracy in the Middle East than is the United States.
Remember that the United States has had very little success in helping create stable democracies in any part of the world over the last two decades, including in its own neighborhood.
Meanwhile, the European Union has a solid track record when it comes to democracy-building, particularly as it relates to the candidate countries of Central and Eastern Europe, its earlier missteps in the Balkans notwithstanding.
For much of the last decade, the world has heard repeatedly about the superiority of the American model. But it has been the European Union that has had the most success in exporting democracy and fostering economic reform.
Moreover, as a continent made up of several of the larger creditor economies, Europe has the financial wherewithal to do more in North Africa and the Middle East as well as in Eastern Europe.
In contrast, the United States is dependent upon European as well as East Asian capital to fuel U.S. growth — and to pay for its international policies.
The nations of the European Union continue to export capital to the developing world as well as to the United States.
In addition, the European Union now has as much or more influence with other key members of the international community — such as Brazil, Russia and Turkey — than the United States does.
More significantly, it often pursues policies that better reflect their interests than American policies do. It thus would be able to enlist them in European projects in a way that the United States has not been able to do.
What is true in the case of the U.S. relationship with Europe is true to a lesser degree with respect to its relationships with Russia, China and Japan.
The United States needs a reasonably strong Russia — and not just to maintain the safety of its nuclear weapons.
It also needs to help balance an increasingly powerful China, check Taliban-like extremists and terrorists in Central Asia and the Caspian Sea, help stop nuclear proliferation in Iran — and stabilize the world oil market.
In return, Washington has very little to offer Moscow, that Russia has recovered its economic independence from the International Monetary Fund and has begun to repatriate substantial sums of capital.
The only exception possibly is a U.S. blessing of Moscow's sometimes misguided effort to crush the Chechen separatists — as well as for Russia's bid for membership in the World Trade Organization.
In recent years, the balance of interest and power with China has shifted to one of mutual dependence.
China has neutralized U.S. power in a number of ways: by modernizing its nuclear forces and by adopting a good neighbor policy in East Asia.
It has also done so by stepping up its diplomacy toward the resolution of the North Korea crisis and by becoming one of the largest suppliers of consumer goods to the United States and one of its biggest creditors.
In 2002, the central bank of China has become the largest purchaser of U.S. Treasury bills.
Together with the Japanese central bank funded 45 % of the U.S. current account deficit in the second quarter of 2003.
China has also become an increasing destination for Japanese goods and capital, including for Japanese companies relocating production abroad.
And China has taken the lead in establishing a free trade zone with the countries of Southeast Asia. This has reduced Japan's dependence on the United States.
It has also strengthened the foundations of an emerging East Asian economic community that one day may represent yet another challenge to America's international economic position.
Neo-conservative supporters of the Bush Administration would prefer to ignore these developments — because they contradict the appealing notion of a unipolar world.
But viewed from the perspective of American strategic relations with Europe and Asia, the central feature of international relations today is not American unipolarity — but the once popular notion of interdependence.
Elsewhere, the troubled underdeveloped regions of the world, struggling with disorder, bad governance and arrested development, if not outright poverty, do not seem to be the beneficiary of American dominance.
In these regions, the central challenge is less any great power competition for influence than the collective weakness of the developed world to do anything about their problems.
Adapted from a longer essay — entitled "Revamping American Grand Strategy" — in the Fall 2003 issue of the World Policy Journal.
Shorting Greece — Or the World?
Should We Trust China?
Adieu to U.S. Unilateralism?
Tags: United States, European Union, democracy, power, unilateralism, superpower, Multipolar, World Policy Journal, Treasury bills
About Sherle Schwenninger
Full bio → | View all posts by Sherle Schwenninger →
Responses to "The Multipolar World Vs. The Superpower"
The Globalist is committed to protecting your online privacy. This Privacy Policy describes how The Globalist uses and protects your personally identifiable data and constitutes an agreement between you and The Globalist. By using our website, you agree to the be governed by our Privacy Policy.
The Globalist is committed to protecting your online privacy. This Privacy Policy describes how The Globalist uses and protects your personally identifiable data and constitutes an agreement between you and The Globalist.
The use of certain cookies is required for the site to function correctly.
Improve content and site performance.


John Gibson has his Badger Bob team pointed in the right direction, the second round draft pick posting a 34 save win - his 6th victory of the season - the Bobs hoping to climb above the .500 mark in Week 7 as they travel to New Baltimore to take on the Polar Bears.
Climbing above .500 is gonna be easier said than done as Badger Bob will be pitted against arguably the hottest team in the league. A pivotal Grimson division clash, the Bobs begin play with a mark of 3-3; the Polar Bears countering with a deceiving record of 2-4.
A non-divisional brawl that features the best team in the FHL and the worst team in the FHL - the Wild Ducks carrying a 5-1 record to the contest; Concussion Junction dragging a 2-4 mark to the match. Need cash for Christmas shopping? Put your money on the Ducks.
Regardless of how the team has fared in the overall standings, the Misconducts have always been a very good H2H team. Nothing has changed in 2018-19, GM Smalley's squad sporting a league-best record of 5-1. The Ice Cats meanwhile are trending in the opposite direction, the underdog Davids, 2-4, still hopeful they can level their Goliath opponent in Week 7.
Losing for just the second time in Week 6, the Boulder Flyers will look to get back on track as they drive (can't afford to fly) to New Jersey to match hockey wits with the Central Red Army. Fresh off a win, the Army will begin play as the slight favorite, the team eager to return to their former home on top of the Domi division.
An all-important Probert division clash as the Bluliners and Ice Hogs lock horns, both teams bringing a 3-3 record to the contest; both teams currently lodged in 2nd place, one game behind the division leader. Based on their record and the level of their recent play, this one should be a humdinger (translated: damn close).
Hoping to end their four game slide, the Vegas Vipers may have picked the wrong opponent - the SC Cobras shredding Week 6 for 55.6 points; over 20.0 points more than the Vipers unearthed. Regardless, the Vipe are gonna give it the old college try, both teams beginning play with identical 2-4 marks.


text:
Deal reached on Iraqi constitution; Sunni party to urge charter approval
Tuesday 11 October 2005 at 8:12 PM ET
by Christopher G. Anderson
[JURIST] In what some Iraqi officials are calling a "breakthrough," Shiite and Kurdish leaders of the Iraqi government [official website, English version] have agreed to allow the country's parliament to review possible future amendments to the Iraqi constitution [JURIST news archive; JURIST document], a demand considered key to winning the support of Iraq's minority Sunni population in the upcoming October 15 referendum [IECI fact sheet, PDF]. Under the eleventh-hour deal announced late Tuesday, a commission will be established to consider amendments to the charter, which would then be voted on by the National Assembly and thereafter submitted to the public in another referendum. This would allow Sunnis to try to amend the constitution to reduce the autonomous powers granted to the majority Shiites and Kurds under the current draft, due to be voted on this weekend. At least one Sunni leader, Ayad al-Samarraie of the Iraqi Islamic Party [GlobalSecurity profile], said the agreement will prompt his party to urge Sunni Arabs to vote in favor of adopting the constitution. According to Iraq's current electoral law, a majority is necessary for the constitution's adoption, unless two-thirds of the citizens in at least three of Iraq's 18 provinces vote "no." With the October referendum coming up on Saturday, the printed copies of the draft constitution now being distributed by the UN [JURIST report] cannot reflect the amendments; instead the changes will be publicized in the Iraqi media, largely on TV. AP has more.
international Iraq Middle East terrorism UK UN


The Caucasian red deer has been spotted in Tusheti Protected Areas after decades of absence.
The Caucasian red deer or Cervus elaphus maral is listed as critically endangered in both the Georgian and Armenian Red Book. It was thought that Georgia had only two very small and isolated populations in Borjomi-Kharagauli National Park and Lagodekhi Strict Nature Reserve. But recent camera trap footage confirms the deer is making a return to the high mountains of Tusheti Protected Areas.
CNF is supporting Tusheti with a three-year operational grant of €284,400; part of the funds are used to purchase essential equipment, such as camera traps, fuel and patrol vehicles. The video footage was made possible by camera traps installed in different areas of the park to help monitor the park's biodiversity.
Historically, the mountains of Tusheti had a rich deer population, but due to years of hunting and encroachment deer numbers have dwindled across the region and the animal was thought to be extinct in Tusheti. Without proper monitoring tools it was impossible to determine whether of not the deer was in the area. Sightings by local shepherds during the summer months gave park administrators hope that the red deer was returning, but it was the camera traps that provided the real proof.
The first images were captured about two years ago and showed a single deer on a hillside, more recent video has shown a group of deer and a mother and baby walking down to a little spring. Experts first thought that the deer had migrated from Lagodekhi, the neighboring protected area, but now there is enough footage from different areas to confirm that the deer is in fact inhabiting the high mountains. Furthermore, the images of the mother and baby confirm that the population is growing!
CNF is working with park administrators to ensure proper measures are in place to reduce poaching and monitor the species so the red deer can once again thrive in Georgia. Visit Tusheti Protected Areas. You may be one of the first visitors to meet the Caucasian deer in person!


text:
Home Politics House Republicans Call for Comprehensive Audit of Pandemic-Related Unemployment Insurance Fraud
House Republicans Call for Comprehensive Audit of Pandemic-Related Unemployment Insurance Fraud
Thirty House members, all Republicans, asked the Labor Department acting inspector general to do an "official audit" of unemployment insurance fraud during the COVID-19 pandemic.
"It is past time we learned how much of American taxpayers' dollars have actually been given to fraudulent claims," the lawmakers wrote in a letter (pdf) to Acting Inspector General Larry Turner on July 8. "We therefore urge that United States Department of Labor, Office of the Inspector General conduct an official audit to determine to what extent did fraud occur in COVID-related unemployment assistance programs."
Reps. Doug Lamborn (R-Colo.), Devin Nunes (R-Calif.), Louie Gohmert (R-Texas), Mo Brooks (R-Ala.), Lauren Boebert (R-Colo.), and 25 other House Republicans coauthored the letter.
The Republicans said that fraudulent activities are still running rampant across the country in unemployment insurance programs, citing a report from Turner's office and a media report.
In the report (pdf) issued on May 28, the Labor Department Office of Inspector General said that the department and states were struggling to implement three pandemic-related unemployment insurance programs including the $600 supplemental unemployment payment. As a result, unemployed individuals can't get timely payments.
Meanwhile, states also have a hard time detecting improper payments and recovering overpayments.
Twenty states didn't perform certain required improper payment detection measures and 19 states didn't perform required overpayment recovery activities, the report stated.
Around $5.4 billion in unemployment insurance benefits was likely paid to potentially fraudulent individuals between March 2020 and October 2020, the Labor Department said in an alert memorandum (pdf) back in February 2021.
Blake Hall, CEO of ID.me, told Axios that about $400 billion, as much as 50 percent of all unemployment payments, might have been stolen.
The Epoch Times reached out to Turner's office for comments.
Many unemployment insurance fraud cases have been charged by U.S. attorneys during the pandemic, according to information released by the Justice Department (DOJ).
Antwine Demon Hunter, 24, from Las Vegas pleaded guilty to filing two dozen fraudulent unemployment insurance claims for over $250,000 on Wednesday.
Several days earlier, a male from Massachusetts, 68-year-old Alan Neal Scott, pleaded guilty in a case connected to pandemic-related unemployment insurance fraud.
Scott "submitted these [fraudulent] claims using his own identity as well as the identities of various individuals, including some who were not eligible for unemployment benefits as they were incarcerated at the time and could not have been employed as reported," the DOJ said in a press release.
The DOJ lists unemployment insurance fraud as one of the four major scams related to COVID-19 on their website.
Previous articlePhotos Catch John Kerry Breaking Biden's Federal Mask Mandate Again
Next articleDOJ Is Creating a Database of Americans and Related Data Collected from the January 6th Protest at the Capitol
'That's F***ed': Joe Rogan Talks Trans Swimmer Destroying Female Competitors, Fallon...


We'd like to invite you to 'Cafe Cambodia and Franchise & Licensing Cambodia 2017 which will be held in 4th – 6th MAY 2017 at Koh Pich (Diamond Island) Convention and Exhibition Center Phnom Penh, Cambodia.
Cafe Cambodia and Franchise & Licensing Cambodia 2017 will present the most comprehensive gathering of cafe and franchise industry players to showcase equipment, machinery, accessories, various supplies and products for the effective and ideal functioning of cafe businesses in Cambodia. It is a one-stop convenient hub for professionals to source for supplies and explore business opportunities with both regional and international counterparts.
These 2 co-located shows are also the first ever dedicated events on the region's café, coffee and tea, baking and franchise industries in Cambodia. As the premier trade and consumer exhibition in Southeast Asia catering to the café, coffee and tea communities, Cafe Cambodia and Franchise & Licensing Cambodia will bring together café owners and managers, coffee and tea exporters and importers as well as distributors and suppliers of café-related machinery and equipment in a dynamic marketplace.


Please Join my Mailing List for Announcements and Special Offers!
Firewall - Manage access to your services to keep your server more secure.
mod_security - Secure common hacks to the Apache web server.
Clamscan - Scan your server for virus infected files.
Note:This package is included in our "Cobalt GUI Unleashed" package!
NOTE: All software is on a "per motherboard" licence and the packages are installed for you to insure the best installation possible. All systems are first checked for fitness before anything is installed... Updates and Reinstallations incurr my minimum charge ($50.00usd)... You will be required to Enter your IP and admin password when prompted by paypal or contact me. All packages are designed to install on a clean system. All systems should be in good running order before package installation. "User group" and other messy servers may require additional charges.
This entire site is Copyright 2009 by Electronic Consultants Incorporated.


You are here: Home / Low Fat / Food & Recipes to help you watch your Weight!
Food & Recipes to help you watch your Weight!
Being a food blogger isn't the best job to have if you want to stay slim so when Weight Watchers asked if I'd like to review some of their products my curiosity got the better of me and I said "yes please"! It's not often you'll find me not cooking from scratch but on those few occasions when I'm too tired or a desperate hurry to get somewhere then it's good to know that there is convenience food out there that's not laden with calories unlike a takeaway. There is a vast range of Weight Watchers products to choose from whether it's chilled, ambient or baked so I chose a few items that would appeal to our taste. I was particularly curious to try the biscuits and wafers as these are things that everyone loves here but can be lethal to a healthy diet.
First up on our voyage of discovery were the Weight Watchers Chewy Caramel Wafers – these went down very well with everyone and we didn't notice anything different about them, just nice chocolate coated wafers with chewy caramel inside.
Then it was the turn of the Belgian Milk Chocolate Digestives. Here we did notice a difference as the biscuit was harder than a standard Digestive, it was more like a cross between a Digestive and a Rich Tea Biscuit but still really enjoyable and the delicious Belgian chocolate gave these Digestives a touch of luxury. The packaging also deserves a mention as the resealable strip makes these the perfect treat to keep in the office drawer or take away on holiday.
Lunch time saw the Weight Watchers Thick Sliced Wholemeal Bread spring into some sandwich action and as my son said he didn't notice anything different, I think the fact that the loaf is smaller than a standard loaf makes your sandwiches less calorific, a good idea as I would rather have less normal tasting bread than a larger slice of something inferior.
Dinner time saw myself and hubby tucking into the Weight Watchers Chilli Con Carne and Potato Wedges which was thicker in consistency than my home made version but I'd happily eat this on a night were cooking was not an option, it had a decent heat to it and paired with a mixed salad a good quick meal.
I do hope you've enjoyed this delve into the world of Weight Watchers and perhaps inspired you to try some of their products or make some of these fabulous recipes.
NB Post commissioned by Weight Watchers and all opinions are my own.
I just started Weight Watchers so this post is perfect timing! I have to look into the WW snack and dessert options…great recipes!
Wow! Lots of fantastic ideas for eating good and eating right! Those caramel wafers look mouth watering good!
I agree that it is not easy to keep slim when you have to bake and test so many yummy treats, my husband keeps blaming me for his extra kilos. Hard to choose between these beauties, I would probably go for all of them, I have such a great tooth.
Thanks Molly, glad you enjoyed this post. Caramel wafers sound like a great place to start.


text:
Roy Williams, Tashard Choice and Super Bowl XII
By Dave Halprin@dave_halprin May 18, 2008, 1:50pm CDT
Share All sharing options for: Roy Williams, Tashard Choice and Super Bowl XII
Sorry for the slow posting lately, but other projects and life intervened. Brandon should be back in action early this week and Tuna Helper may jump back in the fray soon.
Anyway, here's some stuff for today.
Randy Galloway ponders on the Roy Williams situation. We'll see what happens there, but Bigrigga31's poll about Roy Williams is a classic. Out of 534 votes on the question of - Have you ever said aloud, "Roy Williams is my favorite player"? – 266 said yes and 268 said no. That's as close as it gets. Good poll.
DC.com has an article on Tashard Choice, although it's pretty much the same article that we've seen over the past couple of weeks. Like this one.
Want to relive some history? Check this Sports Illustrated article from January 23rd, 1978. Right after the Cowboys whooped the Broncos in Super Bowl XII. It's a long, detailed article and may help you pass away the offseason blues.
As Super Bowls go, the one played indoors last Sunday in New Orleans was way up there for mosts—it had the most fumbles, the most hitting, the most noise, the most penalties, the most tricky plays, and no doubt the most Xs and Os stamped on a coach's forehead, as Dallas' Tom Landry nailed Denver's Red Miller to a blackboard and left him there. And when last seen, the Cowboys' two biggest heroes, Randy White and Harvey Martin, were still lecturing the State of Colorado on the mysteries of the flex defense. As a final gesture of victory, another Cowboy star, Linebacker Tom Henderson, went prancing down the field as the last seconds flashed off and jumped up and stuffed a football over the crossbar. Maybe he thought it was Craig Morton's right arm.
Someone needs to help me out with this article. It's from a West Virginia paper and tries to differentiate Chris Henry from Pacman Jones. The thesis seems to be that Pacman is cocky and arrogant so if his career is over, good riddance. But Henry is just a confused kid who should be forgiven or it would be sad. Yet the article fails miserably to make the differentiation. Or maybe I'm just not seeing the author's point.
From earlier this week, another article on Felix Jones vs. Rashard Mendenhall. My own effort, here.
Bill Parcells and Ricky Williams, best buds?
s it too early to be thinking about our first opponent? If not, then note that Ryan Tucker, a Browns lineman, fractured his hip and will miss two months but is expected to be ready for the opener against Dallas.


He was born in 1970 in Uskudar, where he later completed his general education. In 1988 he got enrolled into the History Department of the Faculty of Natural Sciences and Literature of the Marmara University, and graduated in 1992.
Since 1993 – Researcher of the Social Sciences Division of the Ataturk Education Faculty, Marmara University. In 1996 he graduated from the magistracy, and in 2006 a doctoral program at the Institute of Turkic Studies of the Marmara University in specialty "History of the Middle Ages".
In 1993-1995 he studied Arabic and the history of Islam at the Jordan University, and in 1996-1997 he studied English at the Middle East Technical University. In 2000 he became a researcher in the History Department of the Faculty of Natural Sciences and Literature.
In 2000-2003 carried out research in the history of the Middle Ages in the Department of Islamic Studies and the Middle East at the Edinburgh University . In 2003-2005 worked as a teacher at the Damascus University. In 2011 he received the title of associate professor.
In 2011-2014 He has served as Deputy Director of the Institute for Middle Eastern Studies at Marmara University and Head of the Department of Political History of the Middle East and International Relations. In 2016 he received the title of professor.
From 1998 to 2017 – member of the Turkish Religious Foundation, editorial staff of the Islamic Encyclopedia, Scientific Council on the History of Islam, in 2007-2017. He worked as head of the Research and Publications Department of the Center for Islamic Culture and Art of the Organization of Islamic Cooperation.
There are significant works in the history and culture of the Middle East and the Arab world. In 2017, he was appointed Deputy Rector of Yalova University. In 2017-2018 he was dean of the Faculty of Political Science at the University of Marmara.
There are significant works in the history and culture of the Middle East and the Arab world. In 2017, he was appointed Deputy Rector of Yalova University. In 2017-2018 he was dean of the Faculty of Political Science at the Marmara University.
He speaks English and Arabic, married and has two children.


Hah, I don't often post things like this, but Gizmodo just had a great article reminding us of that time that Microsoft saved Apple. Back in the day, there was a patent fued from Apple, against Microsoft, who had decided that MS had used too much of their 'design' in Windows. As Apple had been in a financial mess, Apple actually had to bend over and apple MS to invest $150 million to keep it afloat. From this, MS got an amazing deal!
Jobs really does deliver the whole thing tongue-in-cheek and the crowd plays along well. The video, from start to end, is a perfect summation of the entire scenario back when Jobs had just re-taken the throne.


text:
package com.intellij.ide.actions.searcheverywhere;

import com.google.common.collect.Lists;
import com.intellij.ide.IdeBundle;
import com.intellij.openapi.actionSystem.AnActionEvent;
import com.intellij.openapi.fileEditor.FileEditorManager;
import com.intellij.openapi.fileEditor.impl.EditorHistoryManager;
import com.intellij.openapi.progress.ProgressIndicator;
import com.intellij.openapi.progress.util.ProgressIndicatorUtils;
import com.intellij.openapi.util.text.StringUtil;
import com.intellij.openapi.vfs.VirtualFile;
import com.intellij.psi.PsiFile;
import com.intellij.psi.PsiManager;
import com.intellij.psi.codeStyle.MinusculeMatcher;
import com.intellij.psi.codeStyle.NameUtil;
import com.intellij.util.Processor;
import com.intellij.util.containers.ContainerUtil;
import org.jetbrains.annotations.NotNull;

import java.util.ArrayList;
import java.util.Arrays;
import java.util.List;
import java.util.stream.Collectors;
import java.util.stream.Stream;

public class RecentFilesSEContributor extends FileSearchEverywhereContributor {

  public RecentFilesSEContributor(@NotNull AnActionEvent event) {
    super(event);
  }

  @NotNull
  @Override
  public String getSearchProviderId() {
    return RecentFilesSEContributor.class.getSimpleName();
  }

  @NotNull
  @Override
  public String getGroupName() {
    return IdeBundle.message("search.everywhere.group.name.recent.files");
  }

  @Override
  public int getSortWeight() {
    return 70;
  }

  @Override
  public int getElementPriority(@NotNull Object element, @NotNull String searchPattern) {
    return super.getElementPriority(element, searchPattern) + 5;
  }

  @Override
  public void fetchWeightedElements(@NotNull String pattern,
                                    @NotNull ProgressIndicator progressIndicator,
                                    @NotNull Processor<? super FoundItemDescriptor<Object>> consumer) {
    if (myProject == null) {
      return; //nothing to search
    }

    String searchString = filterControlSymbols(pattern);
    boolean preferStartMatches = !searchString.startsWith("*");
    NameUtil.MatcherBuilder builder = NameUtil.buildMatcher("*" + searchString);
    if (preferStartMatches) {
      builder = builder.preferringStartMatches();
    }
    MinusculeMatcher matcher = builder.build();
    List<VirtualFile> opened = Arrays.asList(FileEditorManager.getInstance(myProject).getSelectedFiles());
    List<VirtualFile> history = Lists.reverse(EditorHistoryManager.getInstance(myProject).getFileList());

    List<FoundItemDescriptor<Object>> res = new ArrayList<>();
    ProgressIndicatorUtils.yieldToPendingWriteActions();
    ProgressIndicatorUtils.runInReadActionWithWriteActionPriority(
      () -> {
        PsiManager psiManager = PsiManager.getInstance(myProject);
        Stream<VirtualFile> stream = history.stream();
        if (!StringUtil.isEmptyOrSpaces(searchString)) {
          stream = stream.filter(file -> matcher.matches(file.getName()));
        }
        res.addAll(stream.filter(vf -> !opened.contains(vf) && vf.isValid())
                     .distinct()
                     .map(vf -> {
                       PsiFile f = psiManager.findFile(vf);
                       return f == null ? null : new FoundItemDescriptor<Object>(f, matcher.matchingDegree(vf.getName()));
                     })
                     .filter(file -> file != null)
                     .collect(Collectors.toList())
        );

        ContainerUtil.process(res, consumer);
      }, progressIndicator);
  }

  @Override
  public boolean isEmptyPatternSupported() {
    return true;
  }

  @Override
  public boolean isShownInSeparateTab() {
    return false;
  }
}

redpajama_set_name: RedPajamaGithub


Who Do You Think Would Survive A Horror Movie? Part 1!
The question everybody is dying to know the answer to. Do not fear, our cast have the answers!
1. Elizabeth Lail, who plays Amy.
2. Paulina Singer, who plays Jessie.
3. Ronen Rubinstein, who plays Alex.
Who Do You Think Would Survive A Horror Movie?
10 Amazing Cast Moments You Might Have Missed This Week!


text:
Q: How to get current date and timezone of sftp server (date command is not working) I have an sftp server which I used to login using linux terminal using following method:

sftp username@ipofsever

There are files with datename, I just wanted to know the current date & time and timezone of the sftp server.
The output of date command is :
sftp> date
Invalid command.
sftp>

How can I see the current datetime on the server.

A: There's no way to retrieve the current time on an SFTP server.

Though if you have a shell access, you can use a respective command of the shell (like date on *nix systems):
ssh username@example.com date


text:
Medicines for Diabetes (Metformin)
Metformin Criticism
Still No Luck With Ivermectin — based on a study with 1206 participants with confirmed COVID-19, at 93 sites, with a dose of 600 μg/kg
Institute4HealthTransformation (i4ht)
Joaquim Cardoso MSc
Founder and Chief Researcher & Editor
Whether ivermectin, with a maximum targeted dose of 600 μg/kg, shortens symptom duration or prevents hospitalization among outpatients with mild to moderate coronavirus disease 2019 (COVID-19) remains unknown.
Our objective was to evaluate the effectiveness of ivermectin, dosed at 600 μg/kg, daily for 6 days compared with placebo for the treatment of early mild to moderate COVID-19.
ACTIV-6, an ongoing, decentralized, randomized, double-blind, placebo-controlled, platform trial, was designed to evaluate repurposed therapies in outpatients with mild to moderate COVID-19.
A total of 1206 participants age ≥30 years with confirmed COVID-19, experiencing ≥2 symptoms of acute infection for ≤7 days, were enrolled from February 16, 2022, through July 22, 2022, with follow-up data through November 10, 2022, at 93 sites in the US.
Participants were randomized to ivermectin, with a maximum targeted dose of 600 μg/kg (n=602), daily vs. placebo daily (n=604) for 6 days. The primary outcome was time to sustained recovery, defined as at least 3 consecutive days without symptoms.
The 7 secondary outcomes included a composite of hospitalization, death, or urgent/emergent care utilization by day 28.
Among 1206 randomized participants who received study medication or placebo, median (interquartile range) age was 48 (38–58) years; 713 (59%) were women; and 1008 (84%) reported ≥2 SARS-CoV-2 vaccine doses. Median time to recovery was 11 (11–12) days in the ivermectin group and 11 (11–12) days in the placebo group.
The hazard ratio (HR) (95% credible interval [CrI], posterior probability of benefit) for improvement in time to recovery was 1.02 (0.92–1.13; P[HR>1]=0.68).
In those receiving ivermectin, 34 (5.7%) were hospitalized, died, or had urgent or emergency care visits compared with 36 (6.0%) receiving placebo (HR 1.0, 0.6– 1.5; P[HR<1]=0.53).
In the ivermectin group, 1 participant died and 4 were hospitalized (0.8%); 2 participants (0.3%) were hospitalized in the placebo group and there were no deaths.
Adverse events were uncommon in both groups.
Among outpatients with mild to moderate COVID-19, treatment with ivermectin, with a maximum targeted dose of 600 μg/kg daily for 6 days, compared with placebo did not improve time to recovery.
These findings do not support the use of ivermectin in patients with mild to moderate COVID-19.
Figure 3. — Kaplan-Meier for Primary Outcome of Time to Sustained Recovery.
Effect of Ivermectin 600 μg/kg for 6 days vs Placebo on Time to Sustained Recovery in Outpatients with Mild to Moderate COVID-19: A Randomized Clinical Trial
Susanna Naggie, David R. Boulware, Christopher J. Lindsell, Thomas G. Stewart, Stephen C. Lim, Jonathan Cohen, David Kavtaradze, Arch P. Amon, Ahab Gabriel, Nina Gentile, G. Michael Felker, Russell L. Rothman, Dushyantha Jayaweera, Matthew W. McCarthy, Mark Sulkowski, Sybil Wilson, Allison DeLong, April Remaly, Rhonda Wilder, Sean Collins, Sarah E. Dunsmore, Stacey J. Adam, Florence Thicklin, George J. Hanna, Adit A. Ginde, Mario Castro, Kathleen McTigue, Elizabeth Shenkman, Adrian F. Hernandez
Despite treatment advances for coronavirus disease 2019 (COVID-19), the evolution of SARSCoV-2 variants and subvariants has shifted therapeutic options with loss of effectiveness of monoclonal antibodies.
Novel oral antivirals have been authorized for high-risk individuals in high-income countries.1,2
However, efficacy of these antivirals in those vaccinated or with prior infection remains unclear.
Interest remains for the potential of repurposed drugs to improve symptoms and clinical outcomes in patients with COVID-19.
Numerous repurposed drugs have been investigated for COVID-19, with several large, randomized outpatient trials published.3–5 Trial results have been mixed.
Some suggest promise to reduce emergency department (ED) visits or hospitalizations for drugs including fluvoxamine at 100 mg twice daily3 and immediate-release metformin.6
Others have failed to show a reduction in emergency department visits or hospitalizations such as fluvoxamine 50 mg twice daily.6
While recently completed trials benefit from increasing representation of vaccinated people, which is more relevant to the pandemic's current state, the results have not impacted treatment guidelines due to study design and regulatory requirements.7–9
Ivermectin, an anti-parasitic drug used worldwide for onchocerciasis and strongyloidiasis, emerged in 2020 as a potential repurposed drug for COVID-19 informed by an in vitro study suggesting possible anti-viral activity.10
The interest for ivermectin as a COVID-19 therapeutic has remained high and, while there have been numerous ivermectin studies, its use has become controversial due to a lack of high-quality, adequately powered randomized trials and article retractions of some of the earlier and most positive studies.11–14
Three large randomized outpatient trials in people with symptomatic mild or moderate COVID-19 failed to identify a clinical benefit of ivermectin when dosed at 400 µg/kg daily for 3 days.15–17
One possibility is that the dose and duration studied was too low and too short, missing the therapeutic window for ivermectin.
A proof-of-concept randomized controlled clinical trial in hospitalized patients showed that ivermectin, 600 µg/kg, for 5 days suggested possible anti-viral activity with increasing dose.17,18
For this reason we tested ivermectin, with a maximum targeted dose of 600 µg/kg, daily for 6 days on the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV-6) platform from February 16, 2022 through July 22, 2022.
ACTIV-6 is an ongoing, fully remote (decentralized), double-blind, randomized, placebocontrolled, platform trial investigating repurposed drugs for the treatment of mild to moderate COVID-19 in the outpatient setting.
This report describes the effectiveness of this dose and duration of ivermectin compared with blinded placebo for the treatment of early mild to moderate COVID-19.
fda — Why You Shouldn't Use Ivermectin to Treat or Prevent COVID-19
METHODS & OTHER SECTIONS
See the original publication (this is an excerpt version)
Among a largely vaccinated outpatient population with COVID-19, treatment with ivermectin, with a targeted maximum dose of 600 µg/kg, daily for 6 days compared with placebo was not shown to improve time to recovery in over 1200 participants in the US during omicron variant/subvariant circulation.
No evidence of benefit was observed for secondary clinical outcomes including the composite of hospitalization, death, or acute care visits. Hospitalization and death were uncommon in this largely vaccinated population. These find
Multiple large, double-blind randomized controlled trials have failed to identify a clinically meaningful benefit of ivermectin when used at a targeted dose of 400 µg/kg daily for 3 days.6,16
This large clinical trial addresses a potential gap in knowledge by testing 1) a higher daily dose (targeted maximum dose of 600 µg/kg) and 2) longer 6-day duration of ivermectin,. Due to the lack of early phase studies or animal model studies to determine optimal dosing for a therapeutic drug, the appropriate dosing of ivermectin for COVID-19 was never determined. A combination of modeling studies and a proof-of-concept clinical study have suggested doses up to 600 µg/kg daily may achieve system levels sufficient for in vitro antiviral activity.17,18 Although a phase 2 trial testing ivermectin 600 µg/kg daily for 7 days and assessing a virologic endpoint of oropharyngeal SARS-CoV-2 PCR did not show measurable antiviral activity and was stopped for futility.21 This dose was safe and generally well tolerated, with a higher prevalence of the known self-resolving visual disturbances in the intervention arm previously reported with similar doses of ivermectin for parasitic infections.17,18
Recent results from the current platform trial reported participants receiving ivermectin, with a 400 µg/kg, daily for 3 days had a an average ~12-hour shorter time spent unwell when compared with placebo, a secondary outcome for the trial.15
This finding was not replicated here. The notable difference in baseline characteristics between these 2 cohorts is the completed vaccination rate, which is 84% for this study and was 47% for the prior ivermectin 400 µg/kg group.15 Hospitalizations and COVID-19-related clinical events were less common in this largely vaccinated cohort. The incidence of acute care visits, hospitalizations, or death was similar with ivermectin (5.7%) and placebo (6.0%); a result also observed in the two prior ivermectin 400 μg/kg randomized trials in the US.6,15
This trial has several strengths.
This was a double-blind, randomized, placebo-controlled nationwide trial with 93 enrolling sites and a call center that recruited participants from all 50 US states. The ivermectin 600 µg/kg group of the platform trial enrolled rapidly due to ongoing omicron variant/subvariant surges and largely included vaccinated people, thus representing a highly relevant study population that also addresses a weakness of many other studies that excluded vaccinated people.
This study has limitations.
Due to infrequent hospitalization, we cannot draw definitive inferences on whether ivermectin impacts hospitalization without much larger trials.
Also, due to the remote nature of the trial, 60% of participants received study drug within 5 days of symptom onset.
Most outpatient COVID-19 antiviral trials have limited enrollment to participants within 5 days of symptom onset.1,2
In this trial, we observed no evidence of a differential treatment effect based on shorter time to study drug receipt.
Among outpatients with mild or moderate COVID-19, treatment with ivermectin, with a targeted maximum dose of 600 μg/kg daily for 6 days, was not shown to improve time to recovery compared with placebo.
These findings do not support the use of ivermectin in outpatients with COVID-19.
Originally published at https://www.medrxiv.org on December 15, 2022.
Why You Shouldn't Use Ivermectin to Treat or Prevent COVID-19 (FDA)
Por que você não deve usar Ivermectina para tratar ou prevenir a COVID
Durante a pandemia da COVID-19, alguns consumidores parecem estar cada vez mais interessados em recorrer ao uso da…www.fda.gov


text:
Monarchs win in a shootout
Updated: 10:38 PM EST Mar 1, 2013
Manchester Monarchs logo
Monarchs Press Release:The Manchester Monarchs trailed by two goals on three different occasions and tied the game with 43 seconds remaining before defeating the St. John's IceCaps, 5-4 in a shootout, at the MileOne Centre on Friday night.Manchester (25-24-3-3) is in fourth place in the Atlantic Division with 56 points. St. John's (23-30-1-3) is in fifth place in the Atlantic Division with 50 points."This game covered the spectrum, the good, the bad and the ugly," said Monarchs Head Coach Mark Morris. "In the end it was two points. We preserved through moments of disarray and stayed from our systems but to our credit we found a way to take the game to a shootout where Martin Jones stood tall and made stops we needed. The team worked hard. To sweep the weekend, we will have to be better. Both teams will be sharper and more focused after watching video and making adjustments."Center Jordan Weal and left wing Colton Yellow Horn scored for the Monarchs in the shootout. Monarchs goaltender Martin Jones denied center Eric O'Dell, center Ben Maxwell, left wing Jason Jaffrey and left wing Carl Klingberg in the shootout. Right wing Brandon Kozun and right wing Tyler Toffoli were denied in the shootout by IceCaps goaltender Eddie Pasquale. Center Kael Mouillierat scored the lone shootout goal for the IceCaps.The IceCaps opened the scoring on the power play with a goal by center Patrice Cormier at 16:26 of the first period. Mouillierat fed O'Dell on the right wing as the IceCaps gained the Monarchs zone. O'Dell carried the puck to the bottom of the right wing face-off circle before finding Cormier on the left doorstep with a quick pass. Cormier banged it into the back of the net for his sixth goal of the season.St. John's opened a 2-0 lead with a power play goal by O'Dell 12 seconds into the second period. Maxwell fed center Aaron Gagnon before he played the puck to O'Dell who gained the Monarchs zone on the right wing. O'Dell skated to the top of the right wing face-off circle before launching a slap shot that beat Jones high on the stick side for his 17th goal of the season.Kozun scored on the power play for the Monarchs bringing the score to 2-1 at 1:36 of the second period. Weal won a face-off back to defenseman David Kolomatis at the left point. Kolomatis carried the puck to the center point before feeding Kozun at the left point. Kozun skated to the top of the right wing face-off circle before firing a wrist that beat Pasquale for his 20th goal of the season.The IceCaps regained a two-goal lead at 3-1 with a goal by O'Dell at 3:34 of the second period. Defenseman Cody Sol took a slap shot from the right point that produced a rebound on the right doors step. The loose puck bounced around before ricocheting off the end boards where Mouillierat tracked down the puck and played it to O'Dell in front of the net. O'Dell wristed it midway up on the glove side of Jones for his 18th goal of the season.The Monarchs brought the score to 3-2 with a shorthanded goal by Toffoli at 13:17 of the second period. Center Linden Vey played the puck off the right wing half wall in the Monarchs zone where Toffoli grabbed it and skated off on a breakaway. Toffoli continued into the slot with speed before wristing a shot high on the glove side of Pasquale for his 27th goal of the season.Mouillierat tallied another power play goal for the IceCaps making the score 4-2 at 14:21 of the second period. O'Dell took the puck off the left wing half wall before finding Cormier in the slot. Cormier redirected a pass without looking to Mouillierat on the right doorstep. Mouillierat finished the play by burying his seventh goal of the season.The Monarchs scored on the power play with a strike by center Andy Andreoff at 16:15 of the second period. The IceCaps failed to clear the puck out of their zone before Andreoff grabbed the loose puck in the right wing corner. Andreoff skated into the right wing face-off circle before wristing a shot high on the glove side of Pasquale for his seventh goal of the season.Andreoff tied the game for the Monarchs with just 43 seconds remaining in the third period with Jones pulled for an extra skater. Kolomatis took a slap shot from the right point producing a rebound in front of Pasquale. Andreoff fought off a defenseman and slammed home the puck for his eighth goal of the season.Jones (15-19-3) earned his 15th victory of the season of the season stopping 33-of-37 shots in regulation and 4-of-5 shootout attempts. Pasquale (14-19-3) took third shootout loss of the season making 22 saves on 26 shot in regulation and 2-of-4 shootout snipers.Manchester went 2-for-5 on the power play. IceCaps was 3-for-6 with the man advantage.Notables: The Monarchs are 5-0-0-0 in St. John's against the IceCaps dating back to last season…Monarchs center Jordan Weal extended his point streak to four games (2-4=6)…Monarchs right wing Brandon Kozun has nine goals in his last eight games.The Monarchs finish their two-game weekend series against the IceCaps at the MileOne Centre at 6:00 p.m. on Saturday, March 2. Catch all the play-by-play action of Monarchs hockey with Ken Cail on the Monarchs Radio Network WGIR.com and at www.manchestermonarchs.com, presented by Manchester-Boston Regional Airport.
ST. JOHN'S, NL —
Monarchs Press Release:
The Manchester Monarchs trailed by two goals on three different occasions and tied the game with 43 seconds remaining before defeating the St. John's IceCaps, 5-4 in a shootout, at the MileOne Centre on Friday night.
Manchester (25-24-3-3) is in fourth place in the Atlantic Division with 56 points. St. John's (23-30-1-3) is in fifth place in the Atlantic Division with 50 points.
"This game covered the spectrum, the good, the bad and the ugly," said Monarchs Head Coach Mark Morris. "In the end it was two points. We preserved through moments of disarray and stayed from our systems but to our credit we found a way to take the game to a shootout where Martin Jones stood tall and made stops we needed. The team worked hard. To sweep the weekend, we will have to be better. Both teams will be sharper and more focused after watching video and making adjustments."
Center Jordan Weal and left wing Colton Yellow Horn scored for the Monarchs in the shootout. Monarchs goaltender Martin Jones denied center Eric O'Dell, center Ben Maxwell, left wing Jason Jaffrey and left wing Carl Klingberg in the shootout. Right wing Brandon Kozun and right wing Tyler Toffoli were denied in the shootout by IceCaps goaltender Eddie Pasquale. Center Kael Mouillierat scored the lone shootout goal for the IceCaps.
The IceCaps opened the scoring on the power play with a goal by center Patrice Cormier at 16:26 of the first period. Mouillierat fed O'Dell on the right wing as the IceCaps gained the Monarchs zone. O'Dell carried the puck to the bottom of the right wing face-off circle before finding Cormier on the left doorstep with a quick pass. Cormier banged it into the back of the net for his sixth goal of the season.
St. John's opened a 2-0 lead with a power play goal by O'Dell 12 seconds into the second period. Maxwell fed center Aaron Gagnon before he played the puck to O'Dell who gained the Monarchs zone on the right wing. O'Dell skated to the top of the right wing face-off circle before launching a slap shot that beat Jones high on the stick side for his 17th goal of the season.
Kozun scored on the power play for the Monarchs bringing the score to 2-1 at 1:36 of the second period. Weal won a face-off back to defenseman David Kolomatis at the left point. Kolomatis carried the puck to the center point before feeding Kozun at the left point. Kozun skated to the top of the right wing face-off circle before firing a wrist that beat Pasquale for his 20th goal of the season.
The IceCaps regained a two-goal lead at 3-1 with a goal by O'Dell at 3:34 of the second period. Defenseman Cody Sol took a slap shot from the right point that produced a rebound on the right doors step. The loose puck bounced around before ricocheting off the end boards where Mouillierat tracked down the puck and played it to O'Dell in front of the net. O'Dell wristed it midway up on the glove side of Jones for his 18th goal of the season.
The Monarchs brought the score to 3-2 with a shorthanded goal by Toffoli at 13:17 of the second period. Center Linden Vey played the puck off the right wing half wall in the Monarchs zone where Toffoli grabbed it and skated off on a breakaway. Toffoli continued into the slot with speed before wristing a shot high on the glove side of Pasquale for his 27th goal of the season.
Mouillierat tallied another power play goal for the IceCaps making the score 4-2 at 14:21 of the second period. O'Dell took the puck off the left wing half wall before finding Cormier in the slot. Cormier redirected a pass without looking to Mouillierat on the right doorstep. Mouillierat finished the play by burying his seventh goal of the season.
The Monarchs scored on the power play with a strike by center Andy Andreoff at 16:15 of the second period. The IceCaps failed to clear the puck out of their zone before Andreoff grabbed the loose puck in the right wing corner. Andreoff skated into the right wing face-off circle before wristing a shot high on the glove side of Pasquale for his seventh goal of the season.
Andreoff tied the game for the Monarchs with just 43 seconds remaining in the third period with Jones pulled for an extra skater. Kolomatis took a slap shot from the right point producing a rebound in front of Pasquale. Andreoff fought off a defenseman and slammed home the puck for his eighth goal of the season.
Jones (15-19-3) earned his 15th victory of the season of the season stopping 33-of-37 shots in regulation and 4-of-5 shootout attempts. Pasquale (14-19-3) took third shootout loss of the season making 22 saves on 26 shot in regulation and 2-of-4 shootout snipers.
Manchester went 2-for-5 on the power play. IceCaps was 3-for-6 with the man advantage.
Notables: The Monarchs are 5-0-0-0 in St. John's against the IceCaps dating back to last season…Monarchs center Jordan Weal extended his point streak to four games (2-4=6)…Monarchs right wing Brandon Kozun has nine goals in his last eight games.
The Monarchs finish their two-game weekend series against the IceCaps at the MileOne Centre at 6:00 p.m. on Saturday, March 2. Catch all the play-by-play action of Monarchs hockey with Ken Cail on the Monarchs Radio Network WGIR.com and at www.manchestermonarchs.com, presented by Manchester-Boston Regional Airport.


I swear I near this once a week from some otherwise sober people. What does it say about us as a society that so many people believe in something that is so insane?
One hears lots of conspiracy theories about drug companies, it's a good advertising trope for so-called alternative medicine doctors and products -- they don't want you to know about this!!
I actually do think from experience some companies in some circumstances push the line ethically when it comes to clinical trial results and safety claims. But the notion that big pharma is capable of suppressing cures is silly.
PS if you want to read a sobering piece on big pharma, read "Pharmageddon" by Dr. David Healy. Very interesting.
Last edited by Peter_Spaeth; 03-29-2018 at 07:26 AM.
I don't think the conspiracy is full blown or anything but it is true that insurance companies will deny effective treatment if it's too expensive and force a patient to endure lesser treatment for longer periods of time for no real reason at all. In a sense that is keeping a cure from some people.
A young man with whom my son went to school was recently released from the hospital psych unit because the family's coverage ran out. Two days later, he stabbed a man in the grocery store, fortunately not fatally.
Insurance companies will always steer you towards the cheapest alternative. That I agree with 100%.
My mother is currently under treatment and while her team of specialists laid out a sophisticated course of treatments at specialized institutions, her insurance company, who has taken money from her during her entire healthy life when she didn't need the insurance, rejected the proposed treatment. Instead they're forcing her to undergo twice as many therapies over twice the time. And it's not because it's more effective, it's because it's cheaper.
That incident should be a crime. Sorry to hear that and hope your mom gets better.
Thank you for the well wishes. They are appreciated.
My girlfriend's health insurance company tried dropping all coverage on her the very next day after she was diagnosed with stage 3 pancreatic cancer.
I hope your mother gets the treatment she needs and starts to feel better soon.
Thank you. I hope the same for your girlfriend. I've had some people in my life go through that diagnosis as well. I know how daunting it can be.
If you haven't see it yet, be sure to check out "The Rainmaker"
"There's nothing more thrilling than nailing an insurance company"
Who was the last U. S. President to die from cancer?
Who was the last member of the Royal family in England to die from cancer?
Who was the last Astronaut to die from cancer?
Who was the last cancer researcher to die from cancer?
Kemo was first introduced in 1956. It is still used today as the primary treatment of cancer.
That is 62 years without change.
Think about other fields of technology and their advancement over the last 62 years.
The space program, social media, computers, air travel, automobiles, the internet, cost of living, technology..
Yet, we don't have the technology for a cure for cancer.
We supposedly put a man on the moon and back in 1969... but we can't cure cancer.
We can create a life in a test tube.. but we can't cure cancer.
We can clone animals and people.. but we can't cure cancer.
Last edited by 1963Topps Set; 04-08-2018 at 09:34 PM.
"We supposedly put a man on the moon and back in 1969."
I think you ruined your argument right there.
I've heard this many times before too and I completely disagree with it. If drug companies - or any company - did have a cure for cancer, then the rich and powerful would never die from this disease. Look at Steve Jobs, for example. This was a very powerful man with a lot of powerful connections around the world, and yet he died from this disease at a young age. Another example is Fred DeLuca, the founder of Subway, and multi billionaire, who fought this disease for a few years before losing to it at the age of 67.
No I didn't. I don't believe the Government when they say there is no cure for cancer and I don't believe they put a man on the moon. It is either you believe them or you don't. I am consistent in my comments. Otherwise I would be contradicting myself.
About four years ago my cousin's wonderful 3 year old daughter was playfully running around the house like a typical 3 year old does when suddenly she collapsed and couldn't stand up again. They rushed her to the hospital and the doctors discovered a tumor in her brain. She spent the next 3 years undergoing numerous radiation treatments and surgery, spending a huge amount of that time in the hospital.
She had a few months after that of normal life. Then late last year they found that the tumors had returned and spread. These would not respond to radiation treatment and could not be surgically removed. She is not expected to see her next (8th) birthday. My cousin, his ex-wife (her mother) and my aunt (and myself, albeit from afar) can do nothing but watch her condition deteriorate. Its the most excruciatingly painful thing a person can experience - waiting for your kid to die in front of you. She has now spent most of her life, and pretty much all of it that she can remember, dying of cancer.
This happens to millions of people around the world every year. You really think the tens of thousands of people involved in cancer research, many of whom have experienced something similar to this, would just cover up a cure and let this happen to people without a single one of them saying anything about it? That idea is beyond stupid.
Last edited by seanofjapan; 04-09-2018 at 10:39 PM.
Everyone has an opinion on this, I just shared mine. I have seen my share of plenty of people close to me wither in agony and succumb over this dreaded disease too. It makes me appreciate each day even more.
Last edited by 1963Topps Set; 04-10-2018 at 06:17 AM.
US Grant died from throat cancer. It is believed by many that Thomas Jefferson suffered from prostate cancer as well. And I remember Beau Biden, Joe Biden's son, died of brain cancer, which John McCain is also suffering from.
Last edited by packs; 04-11-2018 at 02:30 PM.
1) when I was growing up, it was always batteries that stay charged forever, but that would put battery makers out of business.
which is human drano that kills ALL cells. There is a medical device common in Europe that has been proven to increase blood flow by nearly 30% which has led to some positive effects in this war, if you catch it early enough.
As for Ken's above point # 2, I think some clarification is in order because its' incorrect. Cancer is easily misunderstood.
Cancer can extract oxygen and nutrients from blood, preferentially most of the time. It often outgrows its' budding blood supply and become necrotic because it tends to grow quicker than other cells. Also the reason for weight loss while afflicted, the cancer is preferentially taking nutrients such as glutamine.
The mainstay of most chemotherapy (caveat: The newer monoclonal antibodies etc I am only slightly familiar with) is to target fast-replicating cells, i.e. cancer, which is why other cell lines than turn over quickly (hair, nails, GI lining) feel the brunt as well.
I think the problem most people have with grasping cancer is a fundamental misunderstanding of the disease process. Cancer is your own cells, which through a process too long to discuss here, lose their ability to undergo programmed death when damaged, and essentially proliferate without end, spreading to different parts of the body either locally, through blood, or through lymphatics. When tumor suppressor genes on chromosomes fall off or are damaged/mutated, you can't just pop it back on, though people are researching novel genetic treatments all the time, and I hope they eventually will be successful.
I can tell you what it is . For me, twice, it was surgery. Though when I go for blood tests they tell me no evidence of disease, which does not really mean cured. But I will settle for NED.
Last edited by RichardSimon; 07-06-2018 at 03:41 PM.
The man, who developed one of the first (possibly the first) chemotherapeutic agents (aka Kemo???) in the 1950s, died of cancer in the 1980s. He was a patient in our office.
And his discovery is still used today, most recently by a gentleman I play golf with.
To those people i say there are many companies working on a cure and the one that does will make a truck load of money.
I don't really see why the drug companies would have financial incentive to keep you sick anyway. If you've got insurance, it's the insurer that's going to shoulder the brunt of the cost. If you don't have insurance, the drug company isn't ever getting paid. The insurance companies have just as big a lobby force as the drug companies. I would think it would be in the interest of the insurer to either deny your drugs or keep you healthy so they can get paid for nothing.
Last edited by packs; 07-13-2018 at 04:03 PM.
A close friend of mine is a medical researcher at Oxford. I won't be showing her this thread, as she already mocks Americans (including me) enough as it is . . . She also has less than zero interest in baseball and baseball cards.
There are many things to say on the topic, but I'll leave it at that cancer isn't one thing and a company or person who had the cure for 'cancer' WOULD make a TON of money. There are 15,112,098 people with cancer in the US alone. At whatever-charge X 15,112,098, a company with the cure would make a ton of money. An incredibly modest $10,000 x 15,112,098 = $141,120,980,000, which is more than amazon, Verizon and GE's total worth. And that's only for US cancer patients. Now tell me which company is going to pass that up? And, of course, that $10,000 is so incredibly modest that it's absurd, and any company with the cure for cancer would be the richest company in the world.
Last edited by drcy; 07-14-2018 at 06:36 PM.
Exactly. There is no single company involved, there are hundreds of companies desperate to find a cure for financial or other reasons. There are many thousands of researchers at non-profits and universities looking for a cure. Each would love to be the first to discover a break through. I worked in the genetics industry and was involved in cancer related testing. The incentives are huge for even a minor step forward and there are a ton of independent parties pursuing it.
Also as others have stated, cancer is not a single disease, it is a large category that includes dozens and dozens of diseases.


Ontario's plans to sell pot through a provincially-controlled monopoly are still moving ahead, but Doug Ford's Progressive Conservatives are opening the door to changes once they form government next week.
Ontario's plans to sell marijuana through a provincially-controlled monopoly are still moving ahead, but Doug Ford's Progressive Conservatives are opening the door to changes once they form government next week.
Recreational pot is set to be sold in Ontario only through a new Crown agency called the Ontario Cannabis Retail Corp., an arm of the province's LCBO liquor stores. An online sales portal is due to be up and running as soon as the federal marijuana legalization takes effect, and 40 Ontario Cannabis Store locations are to open by the end of 2018.
On Wednesday, Ford's spokesperson declined to say whether the incoming PC government is sticking with the plan as-is.
"We are currently in the midst of a transition process, and we will have more to say once we form government," said Ford's director of communications, Jeff Silverstein. Ford and his cabinet officially take power on June 29.
Kathleen Wynne's outgoing Liberal government decided the province would control the retail sales market for recreational marijuana. The Liberals brought in legislation to create the cannabis sales agency and to provide for stiff fines on anyone else selling pot.
Shortly after winning the PC leadership in March, Ford floated the prospect of allowing the private sector a piece of the action.
"I don't like the government controlling anything no matter what it is," Ford told CBC's Ottawa Morning. "I'm open to a free market and I'm going to consult with our caucus."
Since then, Ford offered no further specifics about his plans for pot sales, and said little about marijuana retailing during the election campaign that brought him a decisive majority victory. His most concrete pledge was not to allow cannabis stores beside schools, a rule that is already on the province's books.
Sept. 8, 2017: The Wynne government announces plans for government-controlled retailing of recreational weed, with online sales and up to 150 pot shops across the province.
Dec. 12: The full list of 29 municipalities that will host the first 40 pot storefronts is announced.
"I'll keep the kids safe and I won't tolerate any impaired driving with anyone smoking marijuana," Ford said during the first televised debate of the campaign. "This (legalization) is a path we've never gone down before, any of us. So I'm going to work closely with the police. I'm going to consult with the communities, make sure they understand what this is, where we're going."
The provincial agency that will sell marijuana shows no signs of changing its course.
"We appreciate your patience as we work through this complex early stage of setting up operations for the retail sales of legal recreational cannabis," says the website for the Ontario Cannabis Store. The agency put out a call for potential marijuana suppliers to submit bids with a deadline of May 2.
Questions to the Ontario Cannabis Retail Corp. and the LCBO about the plans for marijuana retailing were referred to the province's Ministry of Finance.
"Ontario will be ready for legalization," said ministry spokesperson Scott Blodgett in an email. "The new provincial government will determine how to proceed once it is sworn in."
Bruce Linton, the CEO of marijuana producer Canopy Growth Corp., expressed optimism Wednesday that Ford will eventually allow the private sector into the pot retailing business. He predicts Ontario will launch marijuana sales with the government-controlled model but expand to a hybrid model, as is planned in British Columbia and Newfoundland.
"If other provinces are running private-public mixture, I don't think that it'll look like a really unusual move to make a hybrid here or change it," said Linton in an interview with CBC News.
"This is going to be an ongoing evolution and it's going to be worth watching," said Linton.
Vote Compass: Should only government-run stores sell weed?


text:
1 Girl Nation - 1 Girl Nation
Written by Bert Gangl
For those about to power pop: we salute you!
Label: Reunion Records
Length: 10 tracks (33:55)
Ask most adults about teen-friendly artists like Selena Gomez, R5 and One Direction, and you'll probably get one of two responses. Those in the first group will launch into an extended tirade about how that sort of music isn't really music at all and those who make their living singing teen-pop songs are simply faceless, interchangeable puppets controlled by the behind-the-scenes grown-ups who pull the actual strings. The members of the second cadre, by comparison, are more likely to simply greet you with a blank stare and ask, "Justin who?" Of course, this sort of thing goes both ways, given that the majority of those who have yet to celebrate their 16th birthday are apt to compare the music their parents love and cherish to a recitation of the nearest phone book set to the tune of a funeral dirge.
The five gals of 1 Girl Nation (1GN to the initiated), it seems, may well have found a way to bridge this seemingly bottomless generationally-based chasm. Tweens and early teens are sure to latch onto "Count Your Rainbows" and the equally effervescent "Love Like Crazy," neither of which would sound all that out of place on, say, the Disney Channel's Austin & Ally show. Their older siblings, on the other hand, are equally likely to take a shine to "Vertical," which might just figure prominently into the soundtrack to their next rave. And the stuttering "Invade," which matches like-minded singles like Mandisa's superb "Overcomer" in terms of sheer quality, is sure to be favored by just about everyone in the under-twenty contingent.
On the slightly older side of the coin, Mom and Dad will love cuts such as "Live for You," which harks back, ever so slightly, to the hot-buttered early '70s soul and R&B of artists who made their homes on the Stax and Atlantic Records labels. The terse rhythm and bouncy, minimalistic guitar work of the eponymous "1 Girl Nation," by comparison, owe at least a marginal debt to Carter- and Reagan-era B-52's chestnuts like "Rock Lobster," "Private Idaho" and "Party Out of Bounds." And the anthemic vocals and thundering drums of "While We're Young" are sure to transport parents – and maybe even a few younger grandparents – back to the fall of 1987, when Def Leppard's "Pour Some Sugar on Me" all but ruled radio playlists and the Billboard Hot 100.
Of course, as is the case with any new group, particularly one whose members are this young, one or two cracks in the pavement are bound to appear. The comparison of an earthly dad to one's heavenly Father ("Daddy's Girl"), although certainly noble and appropriate, has arguably been hammered home one too many times already. In the same way, lyrics like "Can't think when I feel your grace/ 'Cause you love me up to outer space" and "You blow my mind/ Like dynamite," both from "Live for You," probably won't send scores of established artists like, say, Andrew Peterson or Nicole Nordeman, over to the 1GN camp begging to collaborate.
That said, with the bulk of the album co-written by the band members, the record, to its credit, rises or falls on the shoulders of its youthful singer/songwriters. And, more importantly, for every track like the ones just mentioned, there are at least as many, such as "Turn Around" and the supremely poignant "In the Eyes" (Among the faces/ You hear their voices say/ You are broken/ So you hide away), whose heartfelt lyrics and sparkling melodies combine to create works of absolute transcendence.
In fairness, even with all of its copious assets, metal heads, emo lovers and pop purists will still probably take one look at the airbrushed, pink-and-purple-laden cover art work and take a pass. For everyone else, though, the superb 1GN debut is sure to reward those with wider-ranging tastes and the willingness to approach the album with open minds - and ears.
– Bert Gangl, the Phantom Tollbooth (10-18-2013)
{module Possibly Related Articles - Also search our Legacy Site}


Will You Accept Mayor Clare's Volunteer Challenge?
Borough Mayor Cllr Clare Head is spearheading a volunteer recruitment drive to encourage more people to give their time to support others in the community. The Mayor is encouraging people to sign up to work with local organisations and charities through Richmond Council for Voluntary Services or to help improve the area where they live through the borough council's Community Resource Bank.
"There are more than 800 voluntary groups in the borough already and thousands of local people give their time, expertise and support to them. These are fantastic organisations and we owe them so much. With a little nudge, even more could be done to help keep them providing the first rate services they run.
"This is the most community-minded borough in London, but it is true that while many of us think volunteering and supporting the community is a good idea, we don't always get round to doing it. I hope that by chatting to people in the street at weekends and showing them the benefits, they will find the time.
On Saturday, 3rd September the Mayor will be joined by representatives from the CRB and Richmond Council for Voluntary Services and will be giving out flyers asking people to think about what they could give in terms of time, knowledge, and resources, like computer work or driving. People will be able to say whether they would like to work with RCVS, the Community Resource Bank or both.
Once they have completed and sent back the form, they will be contacted by representatives of the Council or RCVS to match their time and talents to particular organisations or projects.
Please join the Mayor outside Armstrong's Butchers in St Margarets Road on Saturday, 3rd September from 11.00am to 1.00pm.


text:
Moncrieff
X Factor: Cheryl Loses Two Acts in Tonight's Double Elimination
Cheryl Fernandez-Versini received a double blow in this evening's X Factor as two of her acts were eliminated.
Stephanie Nala was first to leave the show having received the lowest votes from the public. Then, Chloe Jasmine faced a sing-off with eight-piece band Stereo Kicks to try and secure her place for next week.
However, the judges were less than impressed with her performance and although Simon wasn't too keen on the band's performance either and stated that Louis didn't know what he was doing with them, he - along with Louis and Mel B - opted to send Chloe home.
"I feel so grateful to get here, I've had such an amazing time," Stephanie said afterwards.
The show featured performances from Jessie J and Maroon 5 while next week's live shows will have a movie theme.
Simon Cowell,
Cheryl Fernandez-Versini,
Chloe Jasmine,
stereo kicks,
Stephanie Nala.